We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
IG20, in contrast to DENN-SV, (MADD splice variants) suppresses tumor cell survival, and enhances their susceptibility to apoptosis and cancer drugs.
- Authors
Kaithamana, Shashi; Arima, Takayasu; Efimova, Elena V.; Al-Zoubi, Adeeb M.; Martinez, Osvaldo; Shenfeng Lu, Osvaldo; Prabhakar, Bellur S.
- Abstract
We identified seven putative splice variants of the human IG20 gene. Four variants namely, IG20, MADD, IG20-SV2 and DENN-SV are expressed in human tissues. While DENN-SV is constitutively expressed in all tissues, expression of IG20 appears to be regulated. Interestingly, overexpression of DENN-SV enhanced cell replication and resistance to treatments with TNFa, vinblastine, etoposide and ?-radiation. In contrast, IG20 expression suppressed cell replication and increased susceptibility to the above treatments. Moreover, cells that were resistant and susceptible to TNFa-induced apoptosis exclusively expressed endogenous DENN-SV and IG20, respectively. When PA-1 ovarian cancer cells that are devoid of endogenous IG20 variant, but express higher levels of DENN-SV, were transfected with IG20, they showed reduced cell proliferation and increased susceptibility to apoptosis induced by TNFa, TRAIL and ?-radiation. This indicated that overexpression of IG20 can override endogenous DENN-SV function. CrmA reversed the effects of IG20, but not DENN-SV. In contrast, dominant-negative-I-kappa B reversed the effects of DENN-SV, but not IG20, and showed that DENN-SV most likely exerted its effects through NF?B activation. Together, our data show that IG20 gene can play a novel and significant role in regulating cell proliferation, survival and death through alternative mRNA splicing.Oncogene (2004) 23, 1076-1087. doi:10.1038/sj.onc.1207210 Published online 12 January 2004
- Publication
Oncogene, 2004, Vol 23, Issue 5, p1076
- ISSN
0950-9232
- Publication type
Academic Journal
- DOI
10.1038/sj.onc.1207210